DXR - Daxor Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,446.3451,579.2571,688.826
Cost of Revenue652.511727.65704.866
Gross Profit793.834851.607983.96
Operating Expenses
Research Development2,705.9523,041.642,825.151
Selling General and Administrative3,874.2963,469.0783,267.997
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-5,786.414-5,659.111-5,109.188
Income from Continuing Operations
Total Other Income/Expenses Net-6,372.37814,070.94312,261.06
Earnings Before Interest and Taxes-12,327.7158,350.1567,151.872
Interest Expense---
Income Before Tax-12,327.7158,350.1567,151.872
Income Tax Expense-5,142.0763,381.8921,329.114
Minority Interest---
Net Income From Continuing Ops-7,185.6394,968.2645,822.758
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,185.6394,968.2645,822.758
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,185.6394,968.2645,822.758